Cytotoxic, Anti-inflammatory, and Leishmanicidal Activities of Diterpenes Isolated from the Roots of Caesalpinia pulcherrima

Planta Medica

Volumn 83, Issue 1-2, 2017, Pages 104-110

  Erharuyi, Osayemwenre ^a,b   Adhikari, Achyut ^b   Falodun, Abiodun ^a   Jabeen, Almas ^b   Imad, Rehan ^b   Ammad, Muhammad ^b   Choudhary, M Iqbal ^b,c   Gören, Nezhun ^d  

^a UNIVERSITY OF BENIN   (Nigeria)

^b UNIVERSITY OF KARACHI   (Pakistan)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d YILDIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

anti inflammatory activity; Caesalpinia pulcherrima; Caesalpiniaceae; cancer cells; cassane diterpenoids; cytotoxicity; leishmanicidal activity

Indexed keywords

6 BETA HYDROXYISOVOUACAPENOL C; 6BETA CINNAMOYL 7BETA ACETOXYVOUACAPEN 5ALPHA OL; 6BETA CINNAMOYL 7BETA HYDROXYVOUACAPEN 5ALPHA OL; 8,9,11,14 DIDEHYDROVOUACAPEN 5ALPHA OL; AMPHOTERICIN B; ANTIINFLAMMATORY AGENT; ANTILEISHMANIAL AGENT; ANTINEOPLASTIC AGENT; CAESALPINIA PULCHERRIMA EXTRACT; DITERPENE; DOXORUBICIN; IBUPROFEN; PENTAMIDINE; PLANT EXTRACT; PULCHERRIMIN; PULCHERRIMIN B; PULCHERRIMIN C; PULCHERRIMIN D; PULCHERRIMIN E; PULCHERRIN; PULCHERRIN A; PULCHERRIN B; UNCLASSIFIED DRUG; ANTITRYPANOSOMAL AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CAESALPINIA PULCHERRIMA; CANCER CELL; CELL VIABILITY; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DETERMINATION; DRUG HYDROLYSIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; LEISHMANIA MAJOR; PLANT ROOT; RESPIRATORY BURST; THIN LAYER CHROMATOGRAPHY; CAESALPINIA; CHEMICAL STRUCTURE; CHEMISTRY; ISOLATION AND PURIFICATION; TUMOR CELL LINE;

ANTI-INFLAMMATORY AGENTS; CAESALPINIA; CELL LINE, TUMOR; DITERPENES; HUMANS; MOLECULAR STRUCTURE; PLANT ROOTS; TRYPANOCIDAL AGENTS;

EID: 84976448528     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0042-110407     Document Type: Article

References (47)

1. Srinivas K. VNS, Rao Y. K., Mahender I., Das B., Krishna K. VSR, Kishore K. H., Murty U. SN. Flavonoids from Caesalpinia pulcherrima. Phytochemistry: 2003; 63 789 793
2. Chiang L. C., Chiang W., Liu M. C., Lin C. C. In vitro antiviral activity of Caesalpinia pulcherrima and its related flavonoids. J Antimicrob Chemother: 2003; 52 194 198
3. Mahesh G., Ramkanth S., Saleem M. TS. Anti-inflammatory drugs from medicinal plants: a comprehensive review. Int J Rev Life Sci: 2011; 1 1 10
4. Roach J. S., McLean S., Reynolds W. F., Tinto W. F. Cassane diterpenoids of Caesalpinia pulcherrima. J Nat Prod: 2003; 66 1378 1381
5. Promsawan N., Kittakoop P., Boonphong S., Nongkunsarn P. Antitubercular cassane furanoditerpenoids from the roots of Caesalpinia pulcherrima. Planta Med: 2003; 69 776 777
6. Sudhakar M., Rao C. V., Rao P. M., Raju D. B., Venkateswarlu Y. Antimicrobial activity of Caesalpinia pulcherrima, Euphorbia hirta and Asystasia Gangeticum. Fitoterapia: 2006; 77 378 380
7. Pawar C. R., Mutha R. E., Landge A. D., Jadhav R. B., Surana S. J. Antioxidant and cytotoxic activities of Caesalpinia pulcherrima wood. Ind J Biochem Biophy: 2009; 46 198 200
8. Patel S. S., Verma N. K., Chatterjee C., Gauthaman K. Screening of Caesalpinia pulcherrima Linn. flowers for analgesic and anti-inflammatory activities. Int J Appl Res Nat Prod: 2010; 3 1 5
9. Sharma V., Rajani G. P. Evaluation of Caesalpinia pulcherrima Linn. for anti-inflammatory and antiulcer activities. Ind J Pharmacol: 2011; 43 168 171
10. Venkatesalu V., Gopalan N., Pillai C. R., Singh V., Chandrasekaran M., Senthilkumar A., Chandramouli N. In vitro antiplasmodial activity of some traditionally used medicinal plants against Plasmodium falciparum. Parasitol Res: 2012; 111 497 501
11. Kumbhare M., Sivakumar T., Kalantri M., Mahajan V. Investigation of anthelmintic activity of pods of Caesalpinia pulcherrima. J Pharm Res Opin: 2012; 2 63 65
12. WHO Cancer. World Health Organization: 2010; Available at http://www.who.int/cancer/en Accessed April 12, 2016
13. Chu E., Sartorelli A. C. Cancer chemotherapy. In: Katzung B. G. editor Basic and clinical pharmacology, 9th ed. U.S.A. Portland, OR McGraw-Hill: 2004; 888 930
14. Chen Y., Junger W. G. Measurement of oxidative burst in neutrophils. Methods Mol Biol: 2012; 844 115 124
15. Root R. K., Cohen M. S. The microbicidal mechanisms of human neutrophils and eosinophils. Rev Infect Dis: 1981; 3 565 598
16. Dimitrova G., Bunkall C., Lim D., Kendrick C. Comparison of two methods for the diagnosis of chronic granulomatous disease - neutrophil oxidative burst measured by the nitroblue tetrazolium slide test versus the dihydrorhodamine 123 flow cytometric assay. N Z J Med Lab Sci: 2013; 67 45 51
17. Dahlgren C., Karlsson A. Respiratory burst in human neutrophils. J Immun Meth: 1999; 232 3 14
18. Afonso V., Chamy R., Mitrovic D., Collin P., Lomri A. Reactive oxygen species and superoxide dismutases: role in joint diseases. Joint Bone Spine: 2007; 74 324 329
19. Walrand S., Valeix S., Rodriguez C., Ligot P., Chassagne J., Vasson M. P. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin Chim Acta: 2003; 331 103 110
20. Bokoch G. M., Zhao T. Regulation of the phagocyte NADPH oxidase by Rac GTPase. Antiox Redox Signal: 2006; 8 1533 1548
21. Helfand L. S., Werkmeister J., Roder J. C. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence and cytolysis. J Exp Med: 1982; 156 492 505
22. Lundqvist H., Dahlgren C. Isoluminol-enhanced chemiluminescence: a sensitive method to study the release of superoxide anion from human neutrophils. Free Rad Biol Med: 1996; 20 785 792
23. Ashford R. W. The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol: 2000; 30 1269
24. Desjeux P. The increase in risk factors for leishmaniasis. Trans R Soc Trop Med Hyg: 2001; 95 239 243
25. Barrett M. P., Croft S. L. Management of trypanosomiasis and leishmaniasis. Br Med Bull: 2012; 104 175 196
26. de Carvalho P. B., da Arribas M. AG, Ferreira E. I. Braz J Pharm Sci: 2002; 36 69 96
27. Lozano R. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of diseases study 2010. Lancet: 2012; 380 2095 2128
28. Pandy S., Suryawanshi S. N., Gupta S., Srivastava V. ML. Synthesis and antileishmanial profile of some novel terpenyl pyrimidines. Eur J Med Chem: 2004; 39 969 973
29. Minodier P., Parola P. Cutaneous leishmaniasis treatment. Travel Med Infect Dis: 2007; 5 150 158
30. Chan-Bacab M. J., Peña-Rodríguez L. M. Plant natural products with leishmanicidal activity. Nat Prod Rep: 2001; 18 674 688
31. Kayser O., Kiderlen A. F. In vitro leishmanicidal activity of naturally occurring chalcones. Phytother Res: 2001; 15 148 152
32. Rocha L. G., Almeida J. RGS, Macêdo R. O., Barbosa-Filho J. M. A review of natural products with antileishmanial activity. Phytomed: 2005; 12 514 535
33. Atta-ur-Rahman S. Atia-tul-Wahab Choudhary M. I. Discovery of leishmanicidal agents from medicinal plants. Pure Appl Chem: 2008; 80 1783 1790
34. McPherson D. D., Che C., Cordell G. A., Soejarto D. D., Pezzuto J. M., Fong H. HS. Diterpenoids from Caesalpinia pulcherrima. Phytochemistry: 1986; 25 167 170
35. Patil A. D., Freyer A. J., Webb R. L., Zuber G., Reichwein R., Bean M. F., Faucette L., Johnson R. K. Pulcherrimins A-D, novel diterpene dibenzoates from Caesalpinia pulcherrima with selective activity against DNA repair-deficient yeast mutants. Tetrahedron: 1997; 53 1583 1592
36. Ragasa Y., Hofilena J. G., Rideout J. A. Furanoid diterpenes from Caesalpinia pulcherrima. J Nat Prod: 2002; 65 1107 1110
37. Kuroda C., Ueshino T., Nagano H. Ehrlichs reaction of furanoeremophilanes. Bull Chem Soc Japan: 2004; 77 1737 1740
38. Cheenpracha S., Srisuwan R., Karalai C., Ponglimanont C., Chantrapromma S., Chantrapromma K., Fun H. K., Anjum S. Atta-ur-Rahman Diterpenoids from stems and roots of Caesalpinia crista. Tetrahedron: 2005; 61 8656 8662
39. Cheenpracha S., Karalai C., Ponglimanont C., Chantrapromma K., Laphookhieo S. Cassane-type diterpenes from the seeds of Caesalpinia crista. Helv Chem Acta: 2006; 89 1062 1066
40. Pranithanchai W., Karalai C., Ponglimanont C., Subhadhirasakul S., Chantrapromma K. Cassane diterpenoids from the stem of Caesalpinia pulcherrima. Phytochemistry: 2009; 70 300 304
41. Yodsaoue O., Karalai C., Ponglimanont C., Tewtrakul S., Chantrapromma S. Pulcherrins D-R, potential anti-inflammatory diterpenoids from the roots of Caesalpinia pulcherrima. Tetrahedron: 2011; 67 6838 6846
42. Das B., Srinivas Y., Sudhakar C., Mahender I., Laxminarayana K., Reddy P. R., Raju T. V., Jakka N. M., Rao J. V. New diterpenoids from Caesalpinia species and their cytotoxic activity. Bioorg Med Chem Lett: 2010; 20 2847 2850
43. Karlsson A., Markfjall M., Stromberg N., Dahlgren C. Escherichia coli -induced activation of the neutrophil NADPH-oxidase: lipopolysaccharide and formulated peptides act synergistically to induce a release of reactive oxygen metabolites. Infect Immun: 1995; 63 4606
44. Karlsson A., Follin P., Leffler H., Dahlgren C. Galectin-3 activates the NADPH-oxidase in exudated but not peripheral blood neutrophils. Blood: 1998; 91 3430 3438
45. Scudiere D. A., Shoemaker R. H., Paul K. D., Monks A., Tierney S., Nofziger T. H., Currens M. J., Seniff D., Boyd M. R. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res: 1988; 48 4827 4833
46. Koko W. S., Mesaik M. A., Yousaf S., Galal M., Choundary M. I. In vitro immunomodulating properties of selected Sudanese medicinal plants. J Ethnopharmacol: 2008; 118 26 34
47. Choudhary M. I., Yousuf S., Samreen S. A., Yasmeen K. Atta-ur-Rahman Antileishmanial physalins from Physalis minima. Chem Biodiv: 2005; 2 1164 1173